Bartell Drugs to open new Ballard store
SEATTLE — Regional pharmacy retailer Bartell Drugs plans to open a new store in 2016 at Ballard Commons, a mixed-use development planned for the site currently occupied by the Bartell Drugs store at 5605 22nd Ave N.W.
The new store will mark the sixth Bartells location in Ballard since 1911.
The new 14,000-square-foot location will be the major retail anchor at Ballard Commons and will include underground parking for Bartell Drugs customers. Earlier this year, Seattle-based Bartell Drugs opened a full-service “next generation” store at 1500 N.W. Market Street, introducing new services, product offerings and customer convenience features.
Upon closure of the store at 22nd Ave N.W., in January 2015, Bartell Drugs will continue to serve customers at the recently opened Bartell’s location at 15th and Market.
“This is another milestone in our longtime commitment to Ballard. During construction of the new store, we look forward to serving customers at our Market Street location,” stated George D. Bartell, chairman and CEO.
Ballard Commons, a development by Seattle-based Henbart, is a mixed-use development with two contemporary, companion buildings featuring 80 apartments, four townhomes that front Ballard Commons Park, loft-style office space and retail with Bartell Drugs as the anchor tenant. Ballard Commons is designed to include courtyard areas and landscaped grounds, giving it a “campus-like” feel.
Founded in Seattle in 1890, Bartell Drugs operates 63 locations in King, Snohomish and Pierce counties and is the nation's oldest family-owned drug store chain.
Bartell Drugs joins Cigna-HealthSpring’s pharmacy network
SEATTLE — Cigna-HealthSpring Rx, a national Part D plan, has announced that Bartell Drugs’ will be part of its 2015 pharmacy network, accounting for 63 of Cigna-HealthSpring’s 62,000 network pharmacies.
In addition, Bartell Drugs has a preferred cost-share arrangement with Cigna-HealthSpring Rx, which means generally lower costs for Medicare Part D customers with savings on co-pays and co-insurance. The lower costs will provide Part D customers a co-pay savings that will range from $3 to $10 per script.
Enrollment for Medicare beneficiaries began Oct. 15 and will run through Dec. 7.
NACDS RxImpact shines spotlight on pharmacists’ increasing role in delivery of healthcare services
WASHINGTON — Demonstrating pharmacists’ increasingly important role in the delivery of healthcare services, more than 400 community pharmacists, pharmacy executives, pharmacy students and other pharmacy advocates from 40 states participated in the 6th Annual NACDS RxImpact Day on Capitol Hill this week.
Meetings were conducted with more than 80% of the entire U.S. Congress including 136 of 139 Members of Congress who serve on Congressional committees with jurisdiction on healthcare issues.
“The NACDS RxImpact Day on Capitol Hill is an important opportunity for pharmacy advocates from across the country to discuss pro-patient, pro-pharmacy issues with lawmakers in the nation’s capital,” stated NACDS president and CEO Steve Anderson. “Extremely valued by those in greatest need, pharmacies help patients use medicines safely and stay healthy, and provide innovative pharmacy services to improve patient health and quality of life, also helping to improve healthcare affordability.”
This year’s NACDS RxImpact Day on Capitol Hill program included prominent speakers. Mike Allen, chief White House correspondent for the Washington political publication Politico, addressed attendees during the Welcome Dinner on Wednesday evening, providing timely insights on politics in Washington, D.C., and across the nation.
U.S. Representative Fred Upton, R-Mich., served as the keynote speaker at the Breakfast Briefing on Thursday, and received the NACDS Congressional Leadership Award for his commitment to community pharmacy. Upton serves as chairman of the House Energy and Commerce Committee, which has jurisdiction over key pharmacy issues. This week’s NACDS RxImpact Day on Capitol Hill coincided with the introduction of H.R. 4190, which would amend the Social Security Act to designate pharmacists as healthcare providers under the Medicare program.
Under the bill, pharmacists would work to their full capability by providing underserved patients in the Medicare program with services not currently available to them, including immunizations, diabetes screenings and self-management education, cardiovascular screenings and behavioral therapy — within the scope of state laws.
“It is timely that this commonsense, bipartisan legislation was introduced the week of our annual grassroots advocacy fly-in. So we represented in Washington this week that retail pharmacies are oftentimes the most readily accessible healthcare provider. Research has shown that nearly all Americans (89%) live within five miles of a community retail pharmacy,” Anderson stated. “Combined with their expertise and training, pharmacists as healthcare providers can serve their patients to their full capabilities.”
U.S. Senator John Tester, D-Mt., and U.S. Rep. Cathy McMorris Rodgers, R-Wash., also submitted official comments to the Congressional Record in support of their constituents and community pharmacy in lead-up to NACDS RxImpact Day on Capitol Hill.
“Pharmacy has an important part to play — working collaboratively with other healthcare professionals and providers — in providing patient care for those in need,” Anderson added. “And events like the NACDS RxImpact Day on Capitol Hill further reinforce the recognition by lawmakers of that evolving role of pharmacy in patient care.”